国药现代(600420.SH)：全资孙公司获得化学原料药上市申请批准通知书

Core Viewpoint - The company Guoyao Modern (600420.SH) announced that its wholly-owned subsidiary, Jiangsu Weichida Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the active pharmaceutical ingredient, Minaprine Hydrochloride [1] Group 1 - The approved drug, Minaprine Hydrochloride, is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) developed by Pierre Fabre, intended for the treatment of major depressive disorder [1]